Fresh Mobilized Leukopaks | G-CSF + Plerixafor

Fresh Mobilized Leukopaks | G-CSF + Plerixafor

Mobilized Leukopaks are collected from healthy IRB consented donors that are injected with a combination of 10µg/kg/day of Granulocyte-Colony Stimulating Factor (G-CSF) and 240µg/kg of Plerixafor the day before collection, which stimulates the bone marrow to produce hematopoietic stem cells and mobilizes them into the bloodstream, prior to first day of collection. Mobilized mononuclear cells are collected by a trained technician using the Spectra Optia® Apheresis System one and two days post injection. After collection, mobilized Leukopaks are checked by flow analysis to verify the percentage of granulocytes, mononuclear cells, CD34+ cells, and cell viability.

 

  • Custom injection regiments with G-CSF and Plerixafor leading to billions of cells per collection
  • CD34+ and 7 panel emailed on the day of collection to allow researchers to set up reagents in their lab
  • Weekend collections available
  • Isolation of CD34+ to save time on isolations and consumables

The CGT Global Difference 

CGT Global is a Biospecimen Provider for a wide range of clinical and preclinical research projects. Our state-of-the-art laboratories and collection centers are located nationwide and provide end-to-end services: These services include:   

  • Process, isolate, and cryopreserve cells immediately after donor collection 
  • Amazing customer service and fast shipping
  • Customize products to distinct study specifications 
  • Retain specific donor demographics and a safe, highly recallable donor pool 
  • HLA Typed Primary Cells
  • Biobanked cells
CGT Global - Landing Page Desktop Prototype

Description

Human mobilized peripheral blood Leukopaks provide a rich source of hematopoietic stem cells as compared to traditional Leukopaks. This allows researchers greater reproducibility of experiments from a single donor (minimize donor-to-donor variation), increase in scalability of experiments from a single product, and a decrease in same cell variability by obtaining high yields of specific cell types.

• 2x10e10 TNCs/1 bag
• Enriched PBMCs
• Enriched CD34+ cells
• Low hematocrit
• Low granulocytes

Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.

Custom Orders

We work closely with our customers to provide them with the product they need. For a custom order, please call and speak to one of our sales specialists at 530-303-3828.

Additional information

Anticoagulant

Format

Grade

Species

Cell and Tissue Source

Disease State

Donor Attributes

Product Information Sheet

 

Certificate of Analysis

 

Material Safety Data Sheet

 

Protocols

 

Request More Information

Name(Required)
Hidden
Product Interest(Required)
This field is for validation purposes and should be left unchanged.